{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:43:16Z","timestamp":1785800596676,"version":"3.56.0"},"reference-count":50,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2023,11,10]]},"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>This study aims to assess current cardiovascular disease risk and prevalence of risk factors in patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondyloarthritis (SpA).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>2050 consecutive patients with inflammatory arthritis (IA) and 939 controls were included, with 1308 patients with RA, 356 patients with PsA and 386 patients with SpA. In a prospective cohort setting, questionnaires regarding previous cardiovascular events and risk factors were used to assess cardiovascular risk and prevalence in patients with IA by calculating ORs using logistic regression models.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>\u2018Traditional\u2019 cardiovascular (CV) risk factors were significantly elevated in patients with IA compared with controls. Cardiovascular disease (CVD) ORs were increased in patients with RA and PsA compared with controls, 1.61 (95% CI: 1.04 to 2.48) and 2.12 (95% CI: 1.23 to 3.66), respectively, and a trend towards increased odds was observed in patients with SpA (OR 1.43; 95%\u2009CI: 0.79 to 2.59). After adjusting for traditional risk factors, CV risk was not increased in patients with RA (OR; 0.95, 95%\u2009CI: 0.58 to 1.55), PsA (OR 1.19; 95%\u2009CI: 0.64 to 2.22) and SpA (OR; 0.91, 95%\u2009CI: 0.47 to 1.77).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>CVD is currently still more prevalent in patients with IA compared with healthy controls and, more importantly, this elevated risk is highly influenced by an increased prevalence of \u2018traditional\u2019 CV risk factors. More attention to, as well as improvements in, identification and treatment of \u2018traditional\u2019 risk factors, need to be made for not only RA, but other IA conditions as well.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/rmdopen-2023-003485","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T12:22:17Z","timestamp":1701433337000},"page":"e003485","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":21,"title":["Cardiovascular disease risk in patients with inflammatory arthritis nowadays still substantially elevated"],"prefix":"10.1136","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2715-5603","authenticated-orcid":false,"given":"Reinder","family":"Raadsen","sequence":"first","affiliation":[{"name":"Amsterdam Rheumatology and Immunology Center, Amsterdam, Noord-Holland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romy","family":"Hansildaar","sequence":"additional","affiliation":[{"name":"Amsterdam Rheumatology and Immunology Center, Amsterdam, Noord-Holland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianne C","family":"Pouw","sequence":"additional","affiliation":[{"name":"Vrije Universiteit Amsterdam Faculteit der Betawetenschappen, Amsterdam, Noord-Holland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femke","family":"Hooijberg","sequence":"additional","affiliation":[{"name":"Amsterdam Rheumatology and Immunology Center, Amsterdam, Noord-Holland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5473-7786","authenticated-orcid":false,"given":"Laura","family":"Boekel","sequence":"additional","affiliation":[{"name":"Amsterdam Rheumatology and Immunology Center, Amsterdam, Noord-Holland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerrit Jan","family":"Wolbink","sequence":"additional","affiliation":[{"name":"Amsterdam Rheumatology and Immunology Center, Amsterdam, Noord-Holland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arno W R","family":"van Kuijk","sequence":"additional","affiliation":[{"name":"Amsterdam Rheumatology and Immunology Center, Amsterdam, Noord-Holland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6274-1934","authenticated-orcid":false,"given":"Michael T","family":"Nurmohamed","sequence":"additional","affiliation":[{"name":"Amsterdam Rheumatology and Immunology Center, Amsterdam, Noord-Holland, The Netherlands"},{"name":"Department of Rheumatology, Amsterdam UMC Location VUmc, Amsterdam, Noord-Holland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,12,1]]},"reference":[{"key":"2025090312110788000_9.4.e003485.1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200726"},{"key":"2025090312110788000_9.4.e003485.2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209315"},{"key":"2025090312110788000_9.4.e003485.3","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205675"},{"key":"2025090312110788000_9.4.e003485.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2013.07.010"},{"key":"2025090312110788000_9.4.e003485.5","first-page":"505","article-title":"Trends in all-cause and cardiovascular mortality in patients with incident rheumatoid arthritis: a 20-year follow-up matched case-cohort study","volume":"59","author":"Provan","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2025090312110788000_9.4.e003485.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01349-6"},{"key":"2025090312110788000_9.4.e003485.7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/acr.22926","article-title":"Risk of cardiovascular morbidity in patients with psoriatic arthritis: a meta-analysis of observational studies","volume":"69","author":"Polachek","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025090312110788000_9.4.e003485.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2014.10.007"},{"key":"2025090312110788000_9.4.e003485.9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.berh.2019.01.002","article-title":"Cardiovascular morbidity and mortality in ankylosing spondylitis and Psoriatic arthritis","volume":"32","author":"Liew","year":"2018","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2025090312110788000_9.4.e003485.10","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/714321","article-title":"Cardiovascular risk in patients with psoriatic arthritis","volume":"2012","author":"Zhu","year":"2012","journal-title":"Int J Rheumatol"},{"key":"2025090312110788000_9.4.e003485.11","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.136499"},{"key":"2025090312110788000_9.4.e003485.12","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/acr.23567","article-title":"Incidence and prevalence of major adverse cardiovascular events in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis","volume":"70","author":"Lauper","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025090312110788000_9.4.e003485.13","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209775"},{"key":"2025090312110788000_9.4.e003485.14","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab484"},{"key":"2025090312110788000_9.4.e003485.15","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211735"},{"key":"2025090312110788000_9.4.e003485.16","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206411"},{"key":"2025090312110788000_9.4.e003485.17","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.200842"},{"key":"2025090312110788000_9.4.e003485.18","doi-asserted-by":"publisher","DOI":"10.2174\/138161212799504786"},{"key":"2025090312110788000_9.4.e003485.19","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206624"},{"key":"2025090312110788000_9.4.e003485.20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707914"},{"key":"2025090312110788000_9.4.e003485.21","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-002035","article-title":"Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study","volume":"8","author":"Boekel","year":"2022","journal-title":"RMD Open"},{"key":"2025090312110788000_9.4.e003485.22","doi-asserted-by":"publisher","DOI":"10.1002\/art.24836"},{"key":"2025090312110788000_9.4.e003485.23","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202424"},{"key":"2025090312110788000_9.4.e003485.24","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes243"},{"key":"2025090312110788000_9.4.e003485.25","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000122867.89751.59"},{"key":"2025090312110788000_9.4.e003485.26","unstructured":"Feingold KR , Grunfeld C . The effect of inflammation and infection on lipids and lipoproteins. In: Feingold KR , Anawalt B , Boyce A , et al ., eds. Endotext. South Dartmouth (MA), 2019."},{"key":"2025090312110788000_9.4.e003485.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2016.03.004"},{"key":"2025090312110788000_9.4.e003485.28","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/XCE.0000000000000244","article-title":"The relationship between rheumatoid arthritis and diabetes mellitus: a systematic review and meta-analysis","volume":"10","author":"Tian","year":"2021","journal-title":"Cardiovasc Endocrinol Metab"},{"key":"2025090312110788000_9.4.e003485.29","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa246"},{"key":"2025090312110788000_9.4.e003485.30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40744-020-00206-7","article-title":"Psoriatic arthritis and diabetes mellitus: a narrative review","volume":"7","author":"Dal Bello","year":"2020","journal-title":"Rheumatol Ther"},{"key":"2025090312110788000_9.4.e003485.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2005.03.005"},{"key":"2025090312110788000_9.4.e003485.32","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1990.03440200070025"},{"key":"2025090312110788000_9.4.e003485.33","doi-asserted-by":"publisher","DOI":"10.2165\/00007256-199825010-00003"},{"key":"2025090312110788000_9.4.e003485.34","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213585"},{"key":"2025090312110788000_9.4.e003485.35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms151222279"},{"key":"2025090312110788000_9.4.e003485.36","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/rheumatology\/keaa093","article-title":"Smoking in spondyloarthritis: unravelling the complexities","volume":"59","author":"Zhao","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2025090312110788000_9.4.e003485.37","doi-asserted-by":"crossref","first-page":"152233","DOI":"10.1016\/j.semarthrit.2023.152233","article-title":"Male rheumatoid arthritis patients at substantially higher risk for cardiovascular mortality in comparison to women","volume":"62","author":"Raadsen","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"2025090312110788000_9.4.e003485.38","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0428-y"},{"key":"2025090312110788000_9.4.e003485.39","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.170379"},{"key":"2025090312110788000_9.4.e003485.40","doi-asserted-by":"crossref","first-page":"152132","DOI":"10.1016\/j.semarthrit.2022.152132","article-title":"In RA patients without prevalent CVD, incident CVD is mainly associated with traditional risk factors: A 20-year follow-up in the CARRE cohort study","volume":"58","author":"Raadsen","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"2025090312110788000_9.4.e003485.41","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/rheumatology\/kew497","article-title":"Cardiovascular risk management in rheumatoid arthritis patients still suboptimal: the implementation of cardiovascular risk management in rheumatoid arthritis project","volume":"56","author":"van den Oever","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2025090312110788000_9.4.e003485.42","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-021-02599-4","article-title":"Treatment patterns in rheumatoid arthritis patients newly initiated on biologic and conventional synthetic disease-modifying antirheumatic drug therapy and enrolled in a North American Clinical Registry","volume":"23","author":"Mease","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"2025090312110788000_9.4.e003485.43","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/acr.23337","article-title":"Patterns of systemic treatment for Psoriatic arthritis in the US: 2004-2015","volume":"70","author":"Lee","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025090312110788000_9.4.e003485.44","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/14737167.2022.2032663","article-title":"Analysis of the prevalence of Ankylosing Spondylitis and treatment patterns and drug utilization among affected patients: an Italian real-world study","volume":"22","author":"Perrone","year":"2022","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"2025090312110788000_9.4.e003485.45","article-title":"Tumor necrosis factor-alpha inhibitors and cardiovascular risk in rheumatoid arthritis: a systematic review","volume":"14","author":"Nair","year":"2022","journal-title":"Cureus"},{"key":"2025090312110788000_9.4.e003485.46","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2015-000080","article-title":"Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritis","volume":"1","author":"Nurmohamed","year":"2015","journal-title":"RMD Open"},{"key":"2025090312110788000_9.4.e003485.47","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/acr.22144","article-title":"Relationship between metabolic syndrome and carotid intima-media thickness: cross-sectional comparison between psoriasis and psoriatic arthritis","volume":"66","author":"Lin","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025090312110788000_9.4.e003485.48","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/1756-185X.14147","article-title":"Systematic review and meta-analysis on prevalence of metabolic syndrome in psoriatic arthritis, rheumatoid arthritis and psoriasis","volume":"24","author":"Loganathan","year":"2021","journal-title":"Int J Rheum Dis"},{"key":"2025090312110788000_9.4.e003485.49","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41584-019-0256-0","article-title":"Cardiometabolic Comorbidities in RA and PSA: lessons learned and future directions","volume":"15","author":"Ferguson","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"2025090312110788000_9.4.e003485.50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2020.100130","article-title":"Inflammation and cardiovascular disease: from mechanisms to therapeutics","volume":"4","author":"Alfaddagh","year":"2020","journal-title":"Am J Prev Cardiol"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2023-003485","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T19:11:17Z","timestamp":1756926677000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2023-003485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,12,1]]},"published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1136\/rmdopen-2023-003485"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2023-003485","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12]]}}}